MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products

Phase 1
Completed
Conditions
Pain
Interventions
Drug: Active CBD/THC Dose 2
Drug: matched placebo comparator
Drug: Active CBD/THC Dose 1
First Posted Date
2020-01-13
Last Posted Date
2024-07-19
Lead Sponsor
Yale University
Target Recruit Count
24
Registration Number
NCT04226690
Locations
🇺🇸

The Yale Stress Center: Yale University, New Haven, Connecticut, United States

Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma

Early Phase 1
Withdrawn
Conditions
Malignant Melanoma
Interventions
Drug: tremelimumab/durvalumab, ipilimumab/nivolumab and nivolumab monotherapy
First Posted Date
2020-01-10
Last Posted Date
2021-11-22
Lead Sponsor
Yale University
Registration Number
NCT04223648

Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study

Early Phase 1
Conditions
Blood Pressure
Ischemic Stroke
Interventions
First Posted Date
2020-01-06
Last Posted Date
2024-10-03
Lead Sponsor
Yale University
Target Recruit Count
40
Registration Number
NCT04218773
Locations
🇺🇸

Yale-New Haven Hospital, New Haven, Connecticut, United States

Repeat Dosing of Psilocybin in Migraine Headache

Phase 1
Completed
Conditions
Migraine Headache
Interventions
Drug: Placebo
First Posted Date
2020-01-06
Last Posted Date
2024-02-09
Lead Sponsor
Yale University
Target Recruit Count
18
Registration Number
NCT04218539
Locations
🇺🇸

VA Connecticut Healthcare System, West Haven, Connecticut, United States

CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes

Not Applicable
Recruiting
Conditions
Gestational Diabetes
Maternal Complication of Pregnancy
Interventions
Other: Routine Care
Device: Continuous Glucose Monitor
First Posted Date
2020-01-06
Last Posted Date
2024-10-29
Lead Sponsor
Yale University
Target Recruit Count
80
Registration Number
NCT04219085
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Models of Auditory Hallucination

Not Applicable
Terminated
Conditions
Schizo Affective Disorder
Auditory Hallucination
Schizophrenia
Interventions
Device: Transcranial Magnetic Stimulation (TMS)
First Posted Date
2019-12-24
Last Posted Date
2024-08-01
Lead Sponsor
Yale University
Target Recruit Count
1
Registration Number
NCT04210557
Locations
🇺🇸

Connecticut Mental Health Center (CMHC), New Haven, Connecticut, United States

Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

Phase 1
Recruiting
Conditions
Non-small Cell Lung Cancer
Interventions
Radiation: 45 Gray (Gy) regimen
First Posted Date
2019-12-24
Last Posted Date
2025-05-14
Lead Sponsor
Yale University
Target Recruit Count
36
Registration Number
NCT04210492
Locations
🇺🇸

Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut, United States

🇺🇸

Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut, United States

🇺🇸

Smilow Cancer Hospital - Hamden Care Center, Hamden, Connecticut, United States

and more 3 locations

Mobile Physical Activity for Type 1 Diabetes

Not Applicable
Completed
Conditions
Type1diabetes
First Posted Date
2019-12-19
Last Posted Date
2021-05-06
Lead Sponsor
Yale University
Target Recruit Count
20
Registration Number
NCT04204733
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Cannabis Use and Relapse After One Week of Contingency Management Therapy

Not Applicable
Completed
Conditions
Cannabis Dependence
Interventions
Behavioral: Contingency Management + Motivational Interviewing
First Posted Date
2019-12-17
Last Posted Date
2021-11-11
Lead Sponsor
Yale University
Target Recruit Count
49
Registration Number
NCT04202146
Locations
🇺🇸

The Yale Stress Center: Yale University, New Haven, Connecticut, United States

THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis

Phase 1
Completed
Conditions
Cannabis
Ketamine
Interventions
Drug: Active Ketamine
Drug: Placebo Ketamine
First Posted Date
2019-12-16
Last Posted Date
2024-03-25
Lead Sponsor
Yale University
Target Recruit Count
22
Registration Number
NCT04199468
Locations
🇺🇸

VA Connecticut Healthcare System, West Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath